The role of chest computed tomography in the diagnosis of drug-related reactions
Computed tomography (CT) of the chest provides important information toward the diagnosis of drug-induced lung disease. CTs ability to demonstrate subtle parenchymal and pleural changes, small nodules, and adenopathy is valuable in the early detection of drug-related reactions. CT is also of value in monitoring the appearance, progression, and resolution of pulmonary damage in patients receiving potentially toxic drugs. The CT appearances of specific drug reactions are reviewed, including the spectrum of CT findings in bleomycin toxicity and amiodarone-induced lung disease.